The Peptide Ban Is Ending: FDA Peptides Explained Apple Podcasts BPC 157 Ligament: 1 Unsafe Truth BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest